Untitled

First Page		Document Content
Date: 2005-01-30 17:29:13 Molecular biology Viral vector Emerging technologies Medical research LMO2 X-linked severe combined immunodeficiency Severe combined immunodeficiency Retrovirus Common gamma chain Biology Medicine Gene delivery		Untitled Add to Reading List Source URL: angt.austrianova.com Download Document from Source Website File Size: 82,77 KB Share Document on Facebook

	Development of a novel adeno-associated viral vector in combination with tolerogenic nanoparticles for the treatment of Ornithine Transcarbamylase Deficiency Giulia De Sabbata1, Florence Boisgerault2,3, Fanny Collaud2,3, DocID: 1v7ly - View Document
	Controlling Aedes aegypti and Aedes albopictus: Information for vector control programs Background yy Mosquito-borne viral diseases such as chikungunya, dengue, and Zika can cause similar symptoms, including fever with m DocID: 1uPwQ - View Document
	Speakers Boris Kantor, Ph.D. Assistant Professor and Viral Vector Core Director Duke University DocID: 1uirE - View Document
	MIT Committee on Assessment of Biohazards: Policy for Use of Lentiviral Vectors DocID: 1r6Cz - View Document
	BIO 5099: Molecular Biology for Computer Scientists (et al) Lecture 25: Biotechnology http://compbio.uchsc.edu/hunter/bio5099 DocID: 1qu56 - View Document